Anticoccidial Drugs Market

Anticoccidial Drugs Market – By Drug Class (Synthetic Compounds, Polyether Antibiotics or Ionophores), Drug Action (Coccidiostatic, Coccidiocidal), Animal Type (Companion, Livestock), Distribution Channel, Global Forecast (2024 - 2032)

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Anticoccidial Drugs Market Size

Anticoccidial Agents USD 183.1 million is the market size in 2023; from 2024 and 2032 it is expected to rise at a CAGR of 4.1%. The increased demand for protein-rich diets is one of the main causes of the rising demand for poultry goods, such meat and eggs.

To get key market trends

  Download Free Sample

Higher coccidiosis incidence in chicken resulting from this calls for the use of anticoccidial medications for treatment and prevention. Further fuelling the demand for these medications is the intensification of chicken farming methods, meant to meet the growing demand, which has produced a favorable environment for the development of coccidiosis. Moreover, increasing knowledge among farmers about the financial advantages of utilizing anticoccidial medications, such better feed conversion rates and lower mortality rates, is also helping the industry to expand.

Anticoccidional medications are medications used in medicine to treat and prevent coccidiosis, a parasitic condition brought on by protozoa of the genus Eimeria. Animals, poultry, cattle, sheep, goats, swine, and companion animals all have intestinal systems that this protozoon targets. Because of declining productivity, weight loss, and death, coccidiosis can inflict major financial losses on the cattle sector.

Anticoccidial Drugs Market Report Attributes
Report Attribute Details
Base Year 2023
Anticoccidial Drugs Market Size in 2023 USD 183.1 Million
Forecast Period 2024 – 2032
Forecast Period 2024 – 2032 CAGR 4.1%
2024 – 2032 Value Projection USD 262.3 Million
Historical Data for 2021 – 2023
No. of Pages 218
Tables, Charts & Figures 381
Segments covered Drug Class, Drug Action, Animal Type, Distribution Channel, and Region
Growth Drivers
  • Increasing incidence of coccidiosis
  • Growing livestock population
  • Rising demand for animal protein
Pitfalls & Challenges
  • High cost of drug development
  • Stringent regulatory requirements

What are the growth opportunities in this market?

 Download Free Sample

Anticoccidial Drugs Market Trends

  • Expanding to satisfy growing demand for animal products, the world's cattle count is The demand for efficient disease control strategies rises along with the count of cattle animals to guarantee their welfare and output.
  • Using anticoccidial medications is crucial since the higher concentration of animals in farming activities raises the danger of disease transmission including coccidiosis. The increasing number of cattle calls for strong and effective disease preventive strategies, hence increasing the demand for anticoccidial medications.
  • Coccidiosis is spreading more as farming methods get more intense and cattle populations rise.
  • Furthermore, the great cost connected with coccidiosis outbreaks calls for efficient preventive and treatment plans, which fuels the market for anticoccidial medications to preserve animal welfare and output.

Anticoccidial Drugs Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on drug class, the market is segmented into synthetic compounds and polyether antibiotics or ionophores. The synthetic compounds segment dominated the market in 2023 with a market share of 62.1%.

  • Because of their great efficacy and broad spectrum of action against different coccidia species, synthetic chemicals sector has the largest market share.
  • Furthermore, the adaptability of synthetic compounds—available in several forms including injectables, oral solutions, and animal feed additives—allows varied application techniques catered to diverse cattle management approaches.
  • Moreover, availability and economy play other roles influencing the predominance of synthetic substances on the market.

Based on drug action, the anticoccidial drugs market is classified into coccidiostatic and coccidiocidal. The coccidiostatic segment dominated the global market and is anticipated to showcase growth at a CAGR 3.9% between 2024 – 2032.

  • Widely used and shown to be successful in treating coccidiosis in poultry and cattle are coccidostatic medicines. Their great use and market share reflect their general availability and efficiency.
  • Moreover, constant regulatory approval, continuous research and development projects aiming at improving their efficacy and safety, and the proactive preventative strategy connected with their use help to maintain the predominance of coccidiostatic medications in the market.

Learn more about the key segments shaping this market

 Download Free Sample

Based on animal type, the anticoccidial drugs market is divided into companion animals and livestock animals. The companion animals segment held highest market share and was valued at USD 104.7 million in 2023. The companion animals’ segment is further segmented into dogs, cats, and other companion animals.

  • There has been a significant increase in the number of companion animals, such as dogs and cats, kept as pets worldwide. This rise in pet ownership has led to a higher demand for preventive and therapeutic treatments against diseases like coccidiosis in these animals.
  • Additionally, owners are increasingly investing in the health and well-being of their pets, driving the demand for effective anticoccidial drugs.
  • Moreover, advancements in veterinary medicine and an increasing awareness of the health risks associated with coccidiosis in companion animals have propelled the growth of this segment.

Based on distribution channel, the anticoccidial drugs market is categorized into veterinary hospitals & pharmacies, retail pharmacies, and other distribution channels. The veterinary hospitals & pharmacies segment accounted for USD 83.7 million in 2023 and is expected to reach USD 118.8 million by 2032.

  • Veterinary hospitals & pharmacies serve as primary point of access for pet owners and livestock producers to obtain veterinary medications, including anticoccidial drugs. These establishments often have a wide range of products available, making them convenient sources for purchasing these medications.
  • Moreover, the growing emphasis on preventive healthcare for animals, coupled with increasing awareness on the importance of disease management, contributes to the steady demand for anticoccidial drugs from these establishments

Looking for region specific data?

 Download Free Sample

North America anticoccidial drugs market is projected to grow at a CAGR of 3.9% over the forecast period to reach USD 106.8 million by 2032.

  • The region boasts a substantial livestock and poultry industry, where coccidiosis is a prevalent concern. This drives a significant demand for anticoccidial drugs to manage and prevent the disease in animals raised for meat, eggs, and dairy production.
  • Additionally, North America's advanced animal healthcare infrastructure, including clinics, hospitals, and research institutions, supports the diagnosis, treatment, and prevention of coccidiosis, further fueling the demand for these medications.

The U.S. anticoccidial drugs market was valued at USD 70.3 million and is anticipated to experience growth at 3.8% CAGR over the coming years.

  • The country's large livestock population, including poultry and cattle, creates a substantial demand for anticoccidial drugs to prevent and control coccidiosis.
  • Additionally, the presence of key players in the animal health industry, advanced veterinary healthcare infrastructure, and stringent regulations ensuring the quality and safety of animal health products contribute to the dominance of the U.S. market.

Germany anticoccidial drugs market is anticipated to witness lucrative growth in near future.

  • The nation offers a strong veterinary healthcare system including research facilities, hospitals, and modern clinics that help to promote the use of anticoccidional medications.
  • Furthermore driving the demand for safe and efficient veterinary drugs are Germany's strict rules and standards on animal welfare and health, therefore improving the market development.

India anticoccidial drugs market is anticipated to showcase significant growth from 2024 - 2032.

  • A large livestock population in the country, increases the demand for anticoccidial drugs. For instance, according to 20th Livestock Census, the total number of cattle in India was estimated to be 192.49 million in 2019.
  • Farmers and livestock producers in India recognize the economic importance of controlling diseases like coccidiosis, as they can lead to reduced growth rates, decreased milk production, and even mortality among cattle.
  • As a result, there is a growing demand for anticoccidial drugs to manage and prevent the disease in cattle, thereby boosting the market growth.

Anticoccidial Drugs Market Share

The market is characterized by several key players are vying for market share through strategies such as product innovation, partnerships, mergers, and acquisitions. Companies such as Zoetis Inc., Elanco, Merck & Co. Inc., Bayer AG, and Ceva are among the prominent players driving innovation and market growth through the development of novel anticoccidial drugs.

Anticoccidial Drugs Market Companies

Prominent players operating in the anticoccidial drugs industry include

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Cronus Pharma LLC
  • Elanco Animal Health Incorporated
  • Huvepharma EOOD
  • Impextraco NV
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

Anticoccidial Drugs Industry News

  • In May 2019, Bayer launched Baycox, an iron injection combination in Europe for protecting piglets from coccidiosis and iron deficiency. This product launch helped the company to broaden its product portfolio and generate revenue.

The anticoccidial drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments

Click here to Buy Section of this Report

Market, By Drug Class

  • Synthetic compounds
  • Polyether antibiotics or ionophores

Market, By Drug Action

  • Coccidiostatic
  • Coccidiocidal

Market, By Animal Type

  • Companion animals
    • Dogs
    • Cats
    • Other companion animals
  • Livestock animals
    • Cattle
    • Poultry
    • Other livestock animals

Market, By Distribution Channel

  • Veterinary hospitals and pharmacies
  • Retail pharmacies
  • Other distribution channels

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa

 

Related Reports

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email